ARCHIVES

NTP Release Third Report On Carcinogens

This article is from The Cancer Letter archive.

Vol. 10 No. 02 | January 13, 1984

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014